Skip to main content
SpringerLink
Log in

Immunotherapy for Recurrent Miscarriages

  • Chapter
  • First Online:
Recurrent Pregnancy Loss

Abstract

Immunological disturbances have been suggested to play an important role in recurrent miscarriage. Maternal carriage of specific HLA alleles and immunological reactions against male-specific minor antigens have been implicated as causative factors for recurrent miscarriages. Various immunotherapies for treating recurrent miscarriage such as intravenous immunoglobulins, progesterone support, and leukocyte immunization therapy have been discussed in detail in the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216–22.

    Article  Google Scholar 

  2. Shapira E, Ratzon R, Shoham-Vardi I, Serjienko R, Mazor M, Bashiri A. Primary versus secondary recurrent pregnancy loss—epidemiological characteristics, etiology, and next pregnancy outcome. J Perinat Med. 2012;40:389–96.

    Article  Google Scholar 

  3. Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA. 1995;273:1933–6.

    Article  CAS  Google Scholar 

  4. Quack KC, Vassiliadou N, Pudney J, Anderson DJ, Hill JA. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod. 2001;16:949–55.

    Article  CAS  Google Scholar 

  5. Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 2002;187:1313–20.

    Article  CAS  Google Scholar 

  6. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod. 2008;23:972–6.

    Article  CAS  Google Scholar 

  7. King K, Smith S, Chapman M, Sacks G. Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod. 2010;25:52–8.

    Article  CAS  Google Scholar 

  8. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011;342:d2616.

    Article  Google Scholar 

  9. Piosik ZM, Goegebeur Y, Klitkou L, Steffensen R, Christiansen OB. Plasma TNF-a levels are higher in early pregnancy in patients with secondary compared with primary recurrent miscarriage. Am J Reprod Immunol. 2013;70:347–58.

    CAS  PubMed  Google Scholar 

  10. Kruse C, Steffensen R, Varming K, Christiansen OB. A study of HLADR and –DQ alleles in 588 patients and 562 controls confirms that HLA-DRB1*03 is associated with recurrent miscarriage. Hum Reprod. 2004;19:1215–21.

    Article  CAS  Google Scholar 

  11. Nielsen HS, Steffensen R, Varming K, van Halteren AG, Spierings E, Ryder LP, et al. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet. 2009;18:1684–91.

    Article  CAS  Google Scholar 

  12. Christiansen OB, Kolte AM, Dahl M, Larsen EC, Steffensen R, Nielsen HS, et al. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients. Hum Immunol. 2012;73:699–705.

    Article  CAS  Google Scholar 

  13. Nielsen HS, Wu F, Aghai Z, Steffensen R, van Halteren AG, Spierings E, et al. H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male:female ratio in subsequent live births. Hum Reprod. 2010;25:2745–52.

    Article  CAS  Google Scholar 

  14. The German RSA/IVIG Group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. BJOG. 1994;101:1072–7.

    Article  Google Scholar 

  15. Coulam C, Krysa L, Stern J, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol. 1995;34:333–7.

    Article  CAS  Google Scholar 

  16. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod. 1995;10:2690–5.

    Article  CAS  Google Scholar 

  17. Perino A, Vassiliadis A, Vucetich A, Colacurci N, Cignitti M, Semprini AE. Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study. Hum Reprod. 1997;12:2388–92.

    Article  CAS  Google Scholar 

  18. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol. 1998;39:82–8.

    Article  CAS  Google Scholar 

  19. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod. 1999;14:838–41.

    Article  CAS  Google Scholar 

  20. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod. 2002;17:809–16.

    Article  CAS  Google Scholar 

  21. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentred randomized placebo-controlled trial. Hum Reprod. 2010;25:2203–9.

    Article  CAS  Google Scholar 

  22. Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13:176–89.

    Article  CAS  Google Scholar 

  23. Trinath J, Hegde P, Sharma M, Maddur MS, Rabin M, Vallat JM, et al. Intravenous immunoglobulin expands regulating T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood. 2013;122:1419–27.

    Article  CAS  Google Scholar 

  24. Negi V-S, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27:233–45.

    Article  CAS  Google Scholar 

  25. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;2:Art. No. CD000112.

    Google Scholar 

  26. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG. 2007;114:134–42.

    Article  CAS  Google Scholar 

  27. Ata B, Tan SL, Shehata F, Holzer H, Buckett W. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril. 2011;95:1080–5.

    Article  CAS  Google Scholar 

  28. Clark DA. Intravenous immunoglobulin and idiopathic recurrent miscarriage: methodological problems (letter to the Editor). Hum Reprod. 2011;26:2586–7.

    Article  CAS  Google Scholar 

  29. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;(10):CD000112.

    Google Scholar 

  30. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D. Progesterone and maintenance of pregnancy: is progesterone nature’s immunosuppressant? Ann NY Acad Sci. 1977;286:384–97.

    Article  CAS  Google Scholar 

  31. Hansen PJ, Bazer FW, Segerson EC. Skin graft survival in the uterine lumen of ewes treated with progesterone. Am J Reprod Immunol Microbiol. 1986;12:48–54.

    Article  CAS  Google Scholar 

  32. Stites DP, Bugbee S, Siiteri PK. Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation—relevance to immunosuppression in pregnancy. J Reprod Immunol. 1993;5:215–28.

    Article  Google Scholar 

  33. Kruse C, Varming K, Christiansen OB. Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod. 2003;18:2465–72.

    Article  CAS  Google Scholar 

  34. Piccinni MP. T cells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed Online. 2006;13:840–4.

    Article  CAS  Google Scholar 

  35. Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod. 2000;15(Suppl 1):46–59.

    Article  CAS  Google Scholar 

  36. Schindler A. Dydrogesterone: A unique progestogen. Maturitas. 2009;65(Suppl 1):S1.

    Article  Google Scholar 

  37. Raghupathy R, Al Mutawa E, Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent abortion. BJOG. 2005;112:1096–101.

    Article  CAS  Google Scholar 

  38. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol. 1985;9:15–8.

    Article  CAS  Google Scholar 

  39. Szekeres-Bartho J, Polgar B. PIBF: the double edged sword. Pregnancy and tumor. Am J Reprod Immunol. 2010;64:77–86.s.

    CAS  PubMed  Google Scholar 

  40. Karrison TG, Ober C. Recurrent miscarriage (REMIS) study: how should data from women who do not pregnant be handled? Control Clin Trials. 1998;19(5):430–9.

    Article  CAS  Google Scholar 

  41. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101(5):455–8.

    Article  CAS  Google Scholar 

  42. Clark DA, Coulam CB, Stricker RB. Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet. 2006;23:1.

    Article  Google Scholar 

  43. Egerup P, Lindschou J, Gluud C, et al. The effects of intravenous immunoglobulins in women with recurrent miscarriages: a systematic review of randomised trials with meta-analyses and trial sequential analyses including individual patient data. PLoS One. 2015;10:e0141588.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gynae Robotic Surgeon, Institute of Obstetrics and Gynaecology, Sir Ganga Ram Hospital, New Delhi, India

    Mala Srivastava

  2. Lok Nayak Jai Prakash Hospital, New Delhi, India

    Ankita Srivastava

Authors
  1. Mala Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ankita Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mala Srivastava .

Editor information

Editors and Affiliations

  1. Department of Obstetrics & Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta

  2. Department of Obstetrics and Gynecology, UCMS & GTB Hospital, New Delhi, India

    Bindiya Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Srivastava, M., Srivastava, A. (2018). Immunotherapy for Recurrent Miscarriages. In: Mehta, S., Gupta, B. (eds) Recurrent Pregnancy Loss. Springer, Singapore. https://doi.org/10.1007/978-981-10-7338-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7338-0_26

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7337-3

  • Online ISBN: 978-981-10-7338-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation